Cell medicines with Mark Pogson of Regeneron
Nov
19
2024

Nov
19
2024
Description

Mark Pogson, Ph.D., is the Senior Director of Regeneron and will discuss “RNA Cell medicines.” Pogson is a UT alumnus, earning his Molecular Biology Ph.D. in 2012.
This is one talk in a series from Texas Biologics this fall covering cutting-edge technology developments across a range of research fields, from mRNA drug discovery to genetic engineering technologies for de-extinction to biologics design and engineering. Their speakers will include experts from Amgen and Regeneron.
Location
NHB 1.720
Share
Other Events in This Series
Nov
7
2024
Rare disease therapeutics with Jack Borrok of Amgen
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.
9:30 am – 11:00 am • In Person
Speaker(s): Jack Borrock
Feb
13
2025
CMC in the Therapeutic Development Process with Olga Paley of Takeda
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.
11:00 am – 12:00 pm • In Person
Speaker(s): Olga Paley